Cargando…
Reforming the Chimeric Antigen Receptor by Peptide Towards Optimized CAR T Cells With Enhanced Anti-Cancer Potency and Safety
The emerging chimeric antigen receptor (CAR) T cell revolutionized the clinic treatment of hematological cancers, but meet its Waterloo in solid tumor therapy. Although there exist many reasons for this limitation, one of the largest challenges is the scarcity of recognition for tumor cells, resulti...
Autores principales: | Liu, Cuijuan, Li, Lin, Gao, Fan, Zhou, Jundong, Qin, Yingzhou, Yuan, Xin, Yang, Guang, Zhu, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247402/ https://www.ncbi.nlm.nih.gov/pubmed/35782491 http://dx.doi.org/10.3389/fbioe.2022.928169 |
Ejemplares similares
-
Emerging advances in nanobiomaterials-assisted chimeric antigen receptor (CAR)-macrophages for tumor immunotherapy
por: Zhang, Yanan, et al.
Publicado: (2023) -
Determination of CAR T cell metabolism in an optimized protocol
por: Joaquina, Sandy, et al.
Publicado: (2023) -
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
por: Alnefaie, Alaa, et al.
Publicado: (2022) -
Toward high-throughput engineering techniques for improving CAR intracellular signaling domains
por: Butler, Savannah E., et al.
Publicado: (2023) -
Optimization of a Soft Ensemble Vote Classifier for the Prediction of Chimeric Virus-Like Particle Solubility and Other Biophysical Properties
por: Vormittag, Philipp, et al.
Publicado: (2020)